MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment.
metabolism
miR
tumor microenvironment
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
03 Jan 2021
03 Jan 2021
Historique:
received:
09
12
2020
revised:
23
12
2020
accepted:
29
12
2020
entrez:
6
1
2021
pubmed:
7
1
2021
medline:
7
1
2021
Statut:
epublish
Résumé
The metabolism of cancer cells is generally very different from what is found in normal counterparts. However, in a tumor mass, the continuous crosstalk and competition for nutrients and oxygen among different cells lead to metabolic alterations, not only in cancer cells, but also in the different stromal and immune cells of the tumor microenvironment (TME), which are highly relevant for tumor progression. MicroRNAs (miRs) are small non-coding RNAs that silence their mRNA targets post-transcriptionally and are involved in numerous physiological cell functions as well as in the adaptation to stress situations. Importantly, miRs can also be released via extracellular vesicles (EVs) and, consequently, take part in the bidirectional communication between tumor and surrounding cells under stress conditions. Certain miRs are abundantly expressed in stromal and immune cells where they can regulate various metabolic pathways by directly suppressing enzymes or transporters as well as by controlling important regulators (such as transcription factors) of metabolic processes. In this review, we discuss how miRs can induce metabolic reprogramming in stromal (fibroblasts and adipocytes) and immune (macrophages and T cells) cells and, in turn, how the biology of the different cells present in the TME is able to change. Finally, we debate the rebound of miR-dependent metabolic alterations on tumor progression and their implications for cancer management.
Identifiants
pubmed: 33401522
pii: cancers13010127
doi: 10.3390/cancers13010127
pmc: PMC7795884
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG2013-14201DT
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG2017-20258DT
Organisme : Fondazione CRT
ID : 2018.1311DT
Organisme : Regione Piemonte
ID : DEFLECT- 320-44
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : 24188LQ
Références
Nature. 2016 Aug 25;536(7617):479-83
pubmed: 27509858
Blood. 2007 May 1;109(9):3812-9
pubmed: 17255361
J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
Trends Immunol. 2016 Mar;37(3):193-207
pubmed: 26839260
J Immunol. 2018 Oct 1;201(7):2165-2175
pubmed: 30150287
Nat Rev Cancer. 2011 Aug 11;11(9):671-7
pubmed: 21833026
FEBS Lett. 2012 Feb 17;586(4):392-7
pubmed: 22265971
J Biomed Sci. 2019 Jan 12;26(1):7
pubmed: 30634952
Cell. 2015 Sep 10;162(6):1229-41
pubmed: 26321679
Oncotarget. 2017 May 2;8(18):30576-30586
pubmed: 28427165
Nat Rev Immunol. 2020 Jan;20(1):55-70
pubmed: 31406325
Trends Cancer. 2016 Dec;2(12):736-746
pubmed: 28741520
Cancer Lett. 2015 Jan 28;356(2 Pt A):301–8
pubmed: 25451319
Mol Ther. 2018 Aug 1;26(8):2008-2018
pubmed: 29929788
Clin Chem. 2010 Nov;56(11):1733-41
pubmed: 20847327
Clin Exp Immunol. 2019 Aug;197(2):153-160
pubmed: 30873592
Cell Cycle. 2013 Jun 1;12(11):1791-801
pubmed: 23656776
Am J Physiol Endocrinol Metab. 2014 Feb;306(3):E267-74
pubmed: 24326420
Semin Cancer Biol. 2020 Feb;60:214-224
pubmed: 31386907
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Biochim Biophys Acta. 2013 Oct;1831(10):1533-41
pubmed: 23500888
Immunity. 2013 Apr 18;38(4):742-53
pubmed: 23601686
ACS Appl Mater Interfaces. 2017 Sep 13;9(36):30543-30552
pubmed: 28809111
Genes Dev. 2018 Oct 1;32(19-20):1267-1284
pubmed: 30275043
Mol Oncol. 2014 Dec;8(8):1729-46
pubmed: 25091736
Nucleic Acids Res. 2019 Apr 23;47(7):3353-3364
pubmed: 30820533
Ecancermedicalscience. 2014 Jul 10;8:442
pubmed: 25075216
JCI Insight. 2017 Feb 23;2(4):e87489
pubmed: 28239646
Nat Rev Drug Discov. 2017 Mar;16(3):203-222
pubmed: 28209991
Biomaterials. 2016 Apr;85:152-67
pubmed: 26871891
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
Nat Immunol. 2016 Jan;17(1):95-103
pubmed: 26523864
Cell Metab. 2019 Jul 2;30(1):201-211.e6
pubmed: 31056286
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19345-50
pubmed: 18032601
Nat Cell Biol. 2011 Aug 28;13(10):1272-9
pubmed: 21968997
Cancer Res. 2018 Sep 15;78(18):5287-5299
pubmed: 30042153
Cell Metab. 2019 Jul 2;30(1):16-18
pubmed: 31269424
Front Immunol. 2019 Jul 03;10:1462
pubmed: 31333642
Cell Commun Signal. 2013 Oct 29;11:81
pubmed: 24168032
Diabetes Res Clin Pract. 2012 May;96(2):187-95
pubmed: 22245693
Cancer Sci. 2019 Aug;110(8):2368-2377
pubmed: 31222863
Elife. 2017 Jul 24;6:
pubmed: 28737488
Cell Rep. 2016 May 10;15(6):1161-74
pubmed: 27134168
FEBS J. 2018 Feb;285(4):700-716
pubmed: 29055087
Cell. 1993 Dec 3;75(5):843-54
pubmed: 8252621
Nat Cell Biol. 2018 May;20(5):597-609
pubmed: 29662176
Nature. 2011 May 19;473(7347):298-307
pubmed: 21593862
Int J Clin Exp Med. 2014 Oct 15;7(10):3289-96
pubmed: 25419360
Mol Med Rep. 2016 Jun;13(6):4671-6
pubmed: 27082123
Cancer Metastasis Rev. 2014 Sep;33(2-3):823-32
pubmed: 24984804
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
J Clin Invest. 2008 Dec;118(12):3930-42
pubmed: 19033663
Int J Biol Sci. 2018 Jan 11;14(1):100-110
pubmed: 29483829
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Cell Rep. 2016 May 10;15(6):1144-60
pubmed: 27134166
Cancer Cell. 2014 Nov 10;26(5):707-21
pubmed: 25446899
Cell. 2015 Sep 10;162(6):1217-28
pubmed: 26321681
Cancer Lett. 2018 Oct 1;433:10-17
pubmed: 29935373
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Mol Ther Oncolytics. 2019 Dec 25;16:111-123
pubmed: 32021906
Front Immunol. 2019 Aug 02;10:1835
pubmed: 31428105
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3919-24
pubmed: 23407165
Cancer Res. 2012 Oct 1;72(19):5130-40
pubmed: 22850421
Histol Histopathol. 2014 Dec;29(12):1511-24
pubmed: 24921258
Cell Metab. 2006 Mar;3(3):187-97
pubmed: 16517406
Cell. 2017 May 4;169(4):570-586
pubmed: 28475890
Cell Cycle. 2009 Dec;8(23):3984-4001
pubmed: 19923890
Nat Rev Dis Primers. 2018 Jan 18;4:17105
pubmed: 29345251
Annu Rev Biochem. 2010;79:351-79
pubmed: 20533884
PLoS One. 2017 Sep 14;12(9):e0184644
pubmed: 28910332
Cancer Res. 2012 Jun 1;72(11):2746-56
pubmed: 22593198
Nat Rev Clin Oncol. 2018 Jun;15(6):366-381
pubmed: 29651130
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Oncogene. 2019 Jun;38(26):5158-5173
pubmed: 30872795
Cell Rep. 2015 Mar 3;10(8):1335-48
pubmed: 25732824
Mol Cell Biol. 2012 Aug;32(15):3018-32
pubmed: 22645302
Sci Rep. 2018 Aug 27;8(1):12905
pubmed: 30150674
Cancer Lett. 2016 Sep 28;380(1):272-80
pubmed: 26546872
PLoS One. 2012;7(12):e50946
pubmed: 23284651
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9
pubmed: 12434020
Methods Mol Biol. 2020;2097:3-44
pubmed: 31776916
Nat Cell Biol. 2015 Feb;17(2):183-94
pubmed: 25621950
Cell Cycle. 2011 Apr 1;10(7):1144-51
pubmed: 21368581
Antioxid Redox Signal. 2011 Jun 15;14(12):2361-71
pubmed: 21235356
Transl Oncol. 2020 Jan;13(1):57-69
pubmed: 31785429
Immunity. 2019 Jul 16;51(1):27-41
pubmed: 31315034
Science. 2003 Mar 7;299(5612):1540
pubmed: 12624257
Cancers (Basel). 2018 Dec 08;10(12):
pubmed: 30544833
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Nat Immunol. 2013 Jun;14(6):593-602
pubmed: 23603793
Vaccine. 2015 Jun 8;33 Suppl 2:B21-8
pubmed: 26022562
Cell Rep. 2016 May 10;15(6):1134-43
pubmed: 27134180
Genes Dev. 2010 May 15;24(10):992-1009
pubmed: 20413612
Nat Rev Genet. 2009 Oct;10(10):704-14
pubmed: 19763153
Cell Cycle. 2012 Nov 1;11(21):3956-63
pubmed: 23082721
Int J Biol Sci. 2017 Feb 25;13(3):339-348
pubmed: 28367098
Cell Metab. 2006 Mar;3(3):177-85
pubmed: 16517405
Cell Metab. 2016 Nov 8;24(5):701-715
pubmed: 27773694
Annu Rev Immunol. 2013;31:259-83
pubmed: 23298210
Mol Cancer. 2016 May 26;15(1):42
pubmed: 27231010
J Exp Clin Cancer Res. 2019 May 28;38(1):223
pubmed: 31138258
Semin Cell Dev Biol. 2015 Apr;40:72-81
pubmed: 25724562
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Science. 2011 Mar 25;331(6024):1559-64
pubmed: 21436443
Physiol Rev. 2020 Jan 1;100(1):1-102
pubmed: 31414610
Eur J Immunol. 2001 Sep;31(9):2829-38
pubmed: 11536182
J Biol Chem. 2001 Mar 23;276(12):9519-25
pubmed: 11120745
J Immunol. 2017 Aug 15;199(4):1505-1515
pubmed: 28696255
Biochim Biophys Acta. 2016 Oct;1863(10):2465-80
pubmed: 26944480
Sci Adv. 2016 May 27;2(5):e1600200
pubmed: 27386546
Cancer Prev Res (Phila). 2012 Mar;5(3):355-64
pubmed: 22086681
Cell Metab. 2016 Nov 8;24(5):685-700
pubmed: 27829138